stockrowSchrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) Net income
Schrodinger, Inc.'s net income for fiscal 2025 was −$103.3M, compared with −$187.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$59.3M. Over the past ten years it has ranged from −$187.1M (fiscal 2024) to $40.7M (fiscal 2023); the current reading is higher than 33% of that period. Schrodinger, Inc. ranks 33rd of 44 Health Information Services companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$103.3M | — |
| FY2024 | −$187.1M | — |
| FY2023 | $40.7M | — |
| FY2022 | −$149.2M | — |
| FY2021 | −$101.2M | — |
| FY2020 | −$26.6M | — |
| FY2019 | −$25.7M | — |
| FY2018 | −$28.4M | — |
| FY2017 | $0.00 | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | −$37.7M | — |
| Jun 2026 | $6.0M | — |
| Mar 2026 | −$60.0M | — |
| Dec 2025 | $32.5M | — |
| 28 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| OMCL Omnicell, Inc. compare | $44.7M |
| PRVA Privia Health Group, Inc. compare | $38.6M |
| HSTM HealthStream, Inc. compare | $20.5M |
| GDRX GoodRx Holdings, Inc. compare | $16.2M |
| OMDA Omada Health, Inc. compare | $4.3M |
| SDGR Schrodinger, Inc. | −$59.3M |
| CERT Certara, Inc. compare | −$64.3M |
| HTFL Heartflow, Inc. compare | −$118.4M |
| TDOC Teladoc Health, Inc. compare | −$154.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on SDGR
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement